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The number of international tourist arrivals reached 
1,000 million in 2012. Assessment of travellers’ health 
problems has relied on proportionate morbidity data. 
Given the lack of data on number of visitors to each 
region, incidences have been impossible to calculate. 
This study, largest yet reporting travellers’ health 
problems, is the first to present incidence of illness 
and injury. Data on Finnish travellers with health 
problems abroad during 2010 to 2012 were retrieved 
from the database of an assistance organisation, 
SOS International, covering 95% of those requiring 
aid abroad. The numbers were compared with those 
of Finnish travellers in the database of the Official 
Statistics of Finland. The SOS International database 
included 50,710 cases:  infections constituted the 
most common health problem (60%), followed by inju-
ries (14%), diseases of skin (5%), musculoskeletal sys-
tem and connective tissue (5%), digestive tract (3%), 
and vascular system (2%). Gastroenteritis (23%) and 
respiratory infections (21%) proved the most frequent 
diagnoses. Overall incidence of illness or injury was 
high in Africa (97.9/100,000 travel days; 95% Bayesian 
credible interval (BCI): 53.1–145.5), southern Europe 
plus the eastern Mediterranean (92.3; 95% BCI: 75.4–
110.1) and Asia (65.0; 95% BCI: 41.5–87.9). The data 
show significant differences between geographical 
regions, indicating the main risks and thus providing 
destination-specific tools for travellers’ healthcare.
Introduction
The annual number of international tourist arrivals 
globally exceeded 1,000 million in 2012 and is expected 
to reach 1,800 million by 2030 [1]. Of those travelling 
from developed to developing countries, over half have 
been reported to fall ill while abroad and 8% to require 
medical attention [2]. The growing volume of travel 
means an increased burden on healthcare both in host 
countries and at home.
Assessment of travellers’ health problems has largely 
been based on calculations of proportionate morbidity 
of returning travellers as reported by specialised cen-
tres for travel and tropical medicine [3-6]. Data on ill-
ness or injury while abroad have been collected chiefly 
after travel from questionnaires, telephone surveys 
[2,7-14] and insurance claims [15,16], data recorded 
during actual travel are scarce. While a few studies 
have reviewed emergency-assistance services of indi-
vidual insurance companies [17-19], comprehensive 
information on travellers’ health problems abroad is 
non-existent. Furthermore, epidemiological data allow-
ing calculation of the incidence of the whole spectrum 
of health problems in relation to number of travellers 
seem to be completely lacking [20].
The study presented here draws on the particular con-
ditions found in Finland, a country with a population of 
5.5 million [21]. Approximately 95% of those requiring 
help of an assistance organisation because of health 
problems while abroad are recorded in the database 
of SOS International (SOS), serving several insurance 
companies. In addition, Finland is among the few 
countries monitoring their annual number of travel-
lers to various destinations. According to the Official 
Statistics of Finland (OSF) database [22], in 2012 Finns 
made 7.7 million visits abroad in which they stayed for 
at least overnight. Combining these two large datasets 
enabled determination not only of travellers’ propor-
tionate morbidity but, more importantly, also incidence 
of health problems.
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Methods
Assistance organisation data
SOS, serving Nordic and Baltic insurance companies, 
provides travellers with 24-hour emergency assistance 
abroad: advice, medical evaluation, referral to treat-
ment, cost coverage and arrangement of transportation 
if indicated for medical reasons. SOS covers approxi-
mately 95% of all Finnish cases (77% of inpatients, 
99.8% of outpatients) handled abroad by assistance 
organisations (Figure 1); records for 2010 to 2012 were 
included in this analysis.
All SOS data are processed in a computerised data-
base. Coordinating doctors are assigned to approxi-
mately 86% of inpatient and 1% of outpatient cases. 
They stay in contact with the patient and clinician 
abroad, examine medical reports, evaluate treatment 
and give orders for repatriation. Non-medical assis-
tance coordinators see to the uncomplicated inpatient 
and outpatient cases, recording diagnoses provided by 
clinicians abroad.
Information available for our study comprised age, sex, 
time and country of illness or injury, inpatient or out-
patient status, main diagnosis, repatriation and death.
Research clearance was received from SOS.
Definitions
A case was defined as a Finnish traveller abroad with 
one episode of illness or injury, handled by SOS dur-
ing 2010 to 2012. A person with several separate epi-
sodes was counted more than once. Classification as 
inpatient was based on information from the hospital 
abroad. Any case not recorded as an inpatient but who 
had at least one outpatient visit was classified as an 
outpatient case. Deceased travellers who had not been 
registered as inpatients were entered as outpatient 
cases, with their diagnoses being unavailable.
Repatriations were grouped by return: as planned, air 
ambulance, or other rearranged transport. The data 
collection procedure included as inpatients those out-
patient cases whose flights had to be rescheduled.
To describe the study population and proportionate 
morbidity of all cases, countries were classified into 
the following geographical regions: southern Europe 
(the Balkan states, Cyprus, Greece, Italy, Malta, 
Portugal including Madeira, Spain including the Canary 
Islands); rest of Europe; the eastern Mediterranean 
(Israel, Turkey); North Africa; sub-Saharan Africa; 
western Asia; south-central Asia (from Pakistan to 
Bangladesh); south-east Asia; north-east Asia; Central 
and South America and the Caribbean; North America; 
Australia, New Zealand and Oceania. For incidence cal-
culations, the geographical classification was modi-
fied to be compatible with the OSF classification [22].
Travel seasons were categorised by first date of symp-
tom onset or injury, being divided into winter (October 
to March) and summer (April to September).
Diagnoses
Coordinating doctors encoded diagnoses applying the 
International Statistical Classification of Diseases and 
Related Health Problems 10th revision (ICD-10) [23]. 
Assistance coordinators recorded them as open text. 
For our study, a single coordinating doctor, one of the 
researchers (H.S.), encoded these diagnoses by apply-
ing ICD-10. The diagnostic categories were those of 
ICD-10, excluding infections, which we separated from 
the organ-specific classification into a category of their 
own.
Data on Finnish travellers
Obtained from the database of OSF, the pre-existing 
traveller data contained annual numbers and median 
duration of at-least-overnight leisure and business vis-
its abroad, and travellers’ age groups by region and 
country. Country-specific data were available for those 
receiving more than 50,000 visitors per year. OSF data 
had initially been collected by monthly sample-based 
computer-assisted telephone interviews with Finnish 
residents aged 15 to 74 years; the upper age limit was 
extended to 84 years in 2012. Drawn systematically 
Figure 1
Overview of course of Finnish travellers’ health problems 
abroad and study population, 2010–12 (n = 50,710)
a  Source: Federation of Finnish Financial Services. 
Vakuutustutkimus 2012. [Insurance survey 2012] [30].
b  Source: Claims specialist Ilkka Valanne, Eurooppalainen, 
personal communication, 2 October 2013.
c  Source: Medical director Ari Kinnunen, EMA Finland, and 
Medical Director Pauli Haapsaari, MedFlight Finland, personal 
communication, 3 September 2013.
d  Excluded because of incomplete information.
Stayed healthy during travel Fell ill or were injured during travel
Sought medical careDid not seek medical care
Had no travel insurancea
(30%)
378
cases excludedd
Made insurance claim after travelb
(75%)
All Finnish travellers who stayed at least one night abroad
2010–12
n = 14,104,000
Had travel insurance
(70%)
Were reported to the assistance 
organisation used by the insurance
company during travel (25%)
Were handled abroad by other
assistance organisationsc (about 5%)
Were handled
abroad by SOS International
n = 51,088 (about 95%)
Final study population
n = 50,710
3www.eurosurveillance.org
Table 1
Characteristics of outpatient and inpatient casesa among travellers abroad and risk factors for hospitalisation, 2010–12 
(n = 50,710)
Characteristic Total Outpatient cases Inpatient cases P value
Risk factors for hospitalisation
Univariable
OR (95% CI)b
Multivariable 
OR (95% CI)b
Number of cases, n 50,710 42,371 8,339 NA  NA  NA
Sex, n (%) 
Male 22,849 (45.1) 18,500 (43.7) 4,349 (52.2) < 0.001 1.41 (1.34–1.47) 1.33 (1.26–1.40)
Female 27,861 (54.9) 23,871 (56.3) 3,990 (47.8) <0.001 1.00 1.00
 Age in years
Median age (IQR) 45 (21–61) 44 (20–61) 48 (27–64) < 0.001 NA NA 
Age groups, n (%) 
0–14 9,752 (19.2) 8,687 (20.5) 1,065 (12.8) < 0.001 0.59 (0.56–0.62) 0.61 (0.57–0.65)
15–29 6,872 (13.6) 5,528 (13.0) 1,344 (16.1) < 0.001 1.17 (1.10–1.23) 1.08 (1.02–1.15)
30–44 8,373 (16.5) 6,978 (16.5) 1,395 (16.7) 0.132 0.96 (0.91–1.01) 0.85 (0.81–0.91)
45–59 11,135 (22.0) 9,373 (22.1) 1,762 (21.1) < 0.001 0.90 (0.86–0.96) 0.86 (0.82–0.91)
60–74 12,576 (24.8) 10,301 (24.3) 2,275 (27.3) < 0.001 1.06 (1.01–1.11) 1.13 (1.07–1.19)
75–100 2,002 (3.9) 1,504 (3.5) 498 (6.0) < 0.001 1.60 (1.46–1.73) 1.83 (1.66–2.02)
Region, n (%) 
Europe and eastern 
Mediterranean 36,699 (72.4) 31,208 (73.7) 5,491 (65.8) NA NA NA 
Southern Europec 27,202 (53.6) 24,278 (57.3) 2,924 (35.1) < 0.001 0.17 (0.15–0.19) 0.16 (0.14–0.19)
Eastern Mediterraneand 7,539 (14.9) 5,684 (13.4) 1,855 (22.2) < 0.001 0.46 (0.40–0.52) 0.55 (0.48–0.64)
Rest of Europee 1,958 (3.9) 1,246 (2.9) 712 (8.5) 0.004 0.80 (0.68–0.93) 0.73 (0.62–0.85)
Africa 3,262 (6.4) 2,739 (6.5) 523 (6.3) NA NA NA 
North Africa 3,121 (6.2) 2,721 (6.4) 400 (4.8) < 0.001 0.21 (0.18–0.24) 0.28 (0.24–0.33)
Sub-Saharan Africaf 141 (0.3) 18 (0.04) 123 (1.5) < 0.001 9.54 (5.96–15.25) 10.61 (6.54–17.22)
Asia 10,119 (20.0) 8,019 (18.9) 2,100 (25.2) NA NA NA 
South-east Asia 9,514 (18.8) 7,746 (18.3) 1,768 (21.2) < 0.001 0.32 (0.28–0.37) 0.37 (0.32–0.43)
South-central Asiag 361 (0.7) 167 (0.4) 194 (2.3) < 0.001 1.60 (1.29–2.04) 1.77 (1.40–2.25)
North-east Asia 194 (0.4) 90 (0.2) 104 (1.2) 0.001 1.60 (1.21–2.15) 1.49 (1.10–2.03)
Western Asia 50 (0.1) 16 (0.04) 34 (0.4) < 0.001 2.97 (1.70–5.18) 2.96 (1.63–5.37)
The Americas 609 (1.2) 402 (0.9) 207 (2.5) NA NA NA 
Central and South America and 
the Caribbean 366 (0.7) 214 (0.5) 152 (1.8) 0.940 0.99 (0.79–1.25) 1.13 (0.89–1.43)
North America 243 (0.5) 188 (0.4) 55 (0.7) < 0.001 0.41 (0.30–0.55) 0.31 (0.22–0.42)
Australia, New Zealand and 
Oceania 21 (0.04) 3 (0.007) 18 (0.2) < 0.001 8.37 (2.72–25.74) 5.17 (1.64–16.27)
Season, n (%) 
Winterh 30,032 (59.2) 25,054 (59.1) 4,978 (59.7)  NA 1.00 NA 
Summeri 20,678 (40.8) 17,317 (40.9) 3,361 (40.3) 0.337 0.98 (0.93–1.03) NA 
Diagnostic category, n (%) 
Infections 30,386 (59.9) 26,324 (62.1) 4,062 (48.7) NA 1.00 1.00
Injuries 7,095 (14.0) 5,592 (13.2) 1,503 (18.0) < 0.001 1.74 (1.63–1.86) 1.66 (1.55–1.78)
Skin diseases 2,639 (5.2) 2,615 (6.2) 24 (0.3) < 0.001 0.59 (0.04–0.09) 0.058 (0.04–0.09)
Musculoskeletal and connective 
tissue diseases 2,621 (5.2) 2,475 (5.8) 146 (1.8) < 0.001 0.38 (0.32–0.45) 0.38 (0.32–0.46)
Diseases of the digestive tract 1,292 (2.5) 836 (2.0) 456 (5.5) < 0.001 3.54 (3.14–3.98) 3.24 (2.86–3.67)
Vascular diseases 1,081 (2.1) 369 (0.9) 712 (8.5) < 0.001 12.50 (10.98–14.24) 12.40 (10.8–14.2)
Other 5,596 (11.0) 4,160 (9.8) 1,436 (17.2) < 0.001 2.40 (2.09–2.40) 2.30 (2.15–2.48)
CI: confidence interval; IQR: interquartile range; NA: not applicable; OR: odds ratio. 
The values in bold indicate data for main geographical regions.
a  A case was defined as a Finnish traveller abroad with one episode of illness or injury, handled by SOS International during 2010 to 2012. A 
person with several separate episodes was counted more than once. 
b  Deviation from average effect used as reference in variables region and age group.
c  Balkan states, Cyprus, Greece, Italy, Malta, Portugal including Madeira, Spain including Canary Islands.
d  Israel, Turkey.
e  European countries not included in southern Europe.
f  including South Africa.
g  from Pakistan to Bangladesh.
h  From October to March.
i  From April to September.
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from the central population register, the sample 
totalled 26,400 individuals annually in 2010 and 2011, 
and 28,200 in 2012 [22].
Calculation of incidence
Proportionate morbidity figures were retrieved for all 
cases in the SOS database, whereas incidence calcu-
lation was restricted to adults for compatibility with 
the OSF population: only cases aged 15– 74 years in 
2010–11 and 15–84 years in 2012 were included, and 
the geographical classification of OSF was applied 
(Nordic countries, Baltic states and Russia, eastern 
and western Europe; southern Europe and the eastern 
Mediterranean; Africa; Asia and Oceania; the Americas) 
[22].
Incidence figures were calculated as follows:
Total number of travel days = median duration of trip × 
estimated % of travellers with insurance × number of 
travellers
Incidence per 100,000 travel days = (number of cases/
total number of travel days) x 100,000.
Finns have access to state-provided healthcare in coun-
tries following European Union (EU) legislation; reim-
bursement for costs elsewhere can also be obtained by 
application to the Social Insurance Institution of Finland 
(Kela) [24]. As compared with the number of cases han-
dled by SOS, the proportion Kela covers is 50% higher 
in countries following EU legislation than elsewhere. In 
the Nordic and Baltic countries, the proportion exceeds 
50% (Timo Partio, Senior Statistical Analyst, Kela, per-
sonal communication, 7 October 2013) and, further-
more, Finns’ visits to these countries and to Russia are 
Table 2
Characteristics of casesa among travellers abroad by diagnostic category, 2010–12 (n = 50,710)
Characteristic Total Infections Injuries Skin diseases
Musculoskeletal 
and connective 
tissue diseases
Diseases 
of the 
digestive 
tractb
Vascular 
diseasesc Other
d P valuee
Total number, 
n (%) 50,710 (100) 30,386 (59.9) 7,095 (14.0) 2,639 (5.2) 2,621 (5.2) 1,292 (2.5) 1,081 (2.1) 5,596 (11.0) < 0.001
Inpatient cases, 
n (%) 8,339 (16.4) 4,062 (13.4) 1,503 (21.2) 24 (0.9) 146 (5.6) 456 (35.3) 712 (65.9) 1,436 (25.7) < 0.001
Case characteristics 
Male, n (%) 22,849 (45.1) 13,451 (44.3) 3,218 (45.4) 939 (35.6) 1,254 (47.8) 642 (49.7) 621 (57.4) 2,724 (48.7) < 0.001
Median age in 
years (IQR) 45 (21–61) 40 (15–59) 48 (27–62) 46 (23–59) 60 (47–67) 50 (30–63) 64 (56–70) 49 (26–64) < 0.001
Winter seasonf, 
n (%) 30,032 (59.2) 18,380 (60.5) 3,694 (52.1) 1,485 (56.3) 1,638 (62.5) 768 (59.4) 730 (67.5) 3,337 (59.6) < 0.001
Region, n (%)g 
Southern Europe 27,202 (100) 15,406 (56.6) 4,005 (14.7) 1,263 (4.6) 1,806 (6.6) 601 (2.2) 647 (2.4) 3,474 (12.8) < 0.001
Eastern 
Mediterranean 7,539 (100) 4,858 (64.4) 1,008 (13.4) 377 (5.0) 309 (4.1) 204 (2.7) 137 (1.8) 646 (8.6) < 0.001
Rest of Europe 1,958 (100) 840 (42.9) 557 (28.4) 47 (2.4) 61 (3.1) 87 (4.4) 96 (4.9) 270 (13.8) < 0.001
North Africa 3,121 (100) 2,516 (80.6) 189 (6.0) 202 (6.5) 44 (1.4) 56 (1∙8) 13 (0.4) 101 (3.2) < 0.001
Sub-Saharan 
Africa 141 (100) 70 (49.6) 28 (19.9) 1 (0.7) 3 (2.1) 5 (3.5) 4 (2.8) 30 (21.3) < 0.001
South-central 
Asia 361 (100) 257 (71.2) 45 (12.5) 5 (1.4) 5 (1.4) 12 (3.3) 12 (3.3) 25 (6.9) < 0.001
South-east Asia 9,514 (100) 6,081 (63.9) 1,113 (11.7) 711 (7.5) 354 (3.7) 269 (2.8) 141 (1.5) 845 (8.9) < 0.001
North America 243 (100) 60 (24.7) 46 (18.9) 7 (2.9) 18 (7.4) 27 (11.1) 8 (3.3) 77 (31.7) < 0.001
Central and South 
America and the 
Caribbean
366 (100) 220 (60.1) 53 (14.5) 18 (4.9) 9 (2.5) 10 (2.7) 9 (2.5) 47 (12.8) 0.351
Otherh 265 (100) 78 (29.4) 51 (19.2) 8 (3.0) 12 (4.5) 21 (7.9) 14 (5.3) 81 (30.6) < 0.001
a  A case was defined as a Finnish traveller abroad with one episode of illness or injury, handled by SOS International during 2010 to 2012. A 
person with several separate episodes was counted more than once.
b  Other than acute gastroenteritis.
c  Cardiovascular, cerebrovascular, other vascular diseases.
d  Neoplasms; haematological diseases; endocrine, nutritional and metabolic diseases; mental and behavioural disorders; neurological 
diseases; eye diseases; ear diseases; respiratory diseases; genitourinary diseases; pregnancy, childbirth and perinatology; unclassified 
symptoms.
e  Tested using chi-squared test, except for age, for which the Kruskal–Wallis test was used.
f  From October to March.
g  Proportion of diagnostic category according to region (percentages in rows).
h  Western Asia, north-east Asia, Australia, New Zealand, Oceania.
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shorter than elsewhere [22]. As such differences might 
hamper comparison with other regions, we chose not 
to present incidences for the Nordic or Baltic countries 
or Russia.
Statistical methods
Descriptive statistics were analysed with Microsoft 
Excel 2010 and IBM SPSS 19.0. Differences between 
groups were tested with chi-squared and Student’s 
t-tests and the Kruskal–Wallis test, as appropriate. 
Risk factors of hospitalisation were analysed with 
logistic regression. Variables with p < 0.2 in univariable 
analysis were included in a multivariable model. For 
variables lacking a reference category, deviation from 
the average effect was used.
We estimated 95% Bayesian credible intervals (BCIs) 
for travel days of travellers with insurance, and thus 
95% BCIs for incidences, using Bayesian modelling 
with Markov chain Monte Carlo (MCMC) Gibbs sampling 
with informative priors. The following assumptions 
were made: the proportion of travellers with insurance 
was lower (55–70%) for eastern and western Europe 
and higher (75–85%) for more distant destinations; trip 
durations were distributed similarly in all three years 
of the study (2010–12). In estimating the numbers of 
travellers to each destination, sampling variation in the 
numbers of those answering was taken into account.
Results
Study population in the SOS International 
database and case characteristics
The analysis included 50,710 cases; 83.6% were treated 
as outpatients, 16.4% as inpatients. The median age 
was 45 years (interquartile range (IQR): 21–61); 54.9% 
were women (Table 1). Most cases (n = 36,699; 72.4%) 
were reported to SOS in Europe plus the eastern 
Mediterranean. Spain had the highest number, 18,583 
(36.6%), of whom 13,435 (72.3%) were in the Canary 
Islands.
Between regions, characteristics of cases differed 
significantly. Median ages ranged from 31 years (IQR: 
22–45) for cases in north-east and western Asia, 
Australia, New Zealand and Oceania to 52 years (IQR: 
23–65) in southern Europe (p < 0.001). The proportion 
of men ranged from 38.1% of cases in Australia, New 
Zealand, and Oceania to 54.5% of those in south-east 
Asia (p < 0.001). Most cases were reported during win-
ter in all regions except in Europe plus the eastern 
Mediterranean (p < 0.001) (data not shown).
Diagnoses and repatriations
Infections (59.9%) and injuries (14.0%) constituted the 
largest diagnostic categories for outpatients and inpa-
tients alike (Table 1, Table 2). The risk of hospitalisation 
proved greatest among cases with vascular diseases. 
Multivariable analyses showed other risk factors of 
hospitalisation to be male sex, aged 15–29 or ≥ 60 
years, and travel to sub-Saharan Africa, Australia, New 
Zealand and Oceania, or to Asia (other than south-east 
Asia) (Table 1). Significant interactions were found 
between all these variables.
Acute gastroenteritis (11,543 cases) proved both the 
most common diagnosis (22.8% of all) and infection 
(38.0%). Respiratory tract infections (n = 10,475) were 
nearly as common (20.7% of all, 34.5% of infections). 
Injuries comprised 5,567 (78.5%) traumas and 1,528 
(21.5%) others. Of the traumas, 4,270 (76.7%) were 
superficial, 952 (17.1%) fractures and 287 (5.2%) intrac-
ranial injuries.
Return travel itineraries remained unchanged for 
48,842 cases (96.3%), an air ambulance was used for 
113 (0.2%), and 1,556 (3.1%) had some other changed 
transport arrangement. Deaths totalled 199 (0.4%).
Incidence of illness or injury
Overall incidence of illness and injury was great-
est in Africa and southern Europe plus the eastern 
Mediterranean, as well as Asia plus Oceania; inci-
dences were lowest in the Americas and eastern plus 
western Europe (Table 3, Figure 2). Looking at individ-
ual countries’ data available for comparison, incidence 
Figure 2
Overall incidencea of illness and injury among adultb 
Finnish travellers in various regionsc, 2010–12 
(9,953,000 travellers) 
The bars represent 95% Bayesian credible intervals.
a  Incidence per 100,000 travel days = (number of cases divided by 
number of travel days) x 100,000.
b  Travellers aged 15–74 years in 2010–11 and travellers aged 
15–84 years in 2012 [22]. 
c  Figures for Nordic and Baltic countries and Russia are not 
presented here; incidences for these countries are not 
comparable with those of other regions because proportionally 
more cases are covered by the Social Insurance Institution of 
Finland (Kela) [24] and trips are shorter than to other regions 
[22].
d  Balkan states, Cyprus, Greece, Italy, Israel, Malta, Portugal 
including Madeira, Spain including the Canary Islands, Turkey.
Data source: Table 3.
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Table 4
Incidence of injuries and infections among adult Finnish travellersa in various geographical regionsb and selected countriesc, 
2010–12 (9,953,000 travellers)
Regions and 
countries visitedb,c
Number of casesd,e
and incidence (per 100,000 travel days)f of injuries and infections among adult travellers
Largest diagnostic main categories Largest infection subcategories
Injuries total Infections total Acute gastroenteritis Acute respiratory infections
Regions and 
countries with more 
than 50,000 Finnish 
travellers/year
Number Incidence(95% BCI) Number
Incidence
(95% BCI) Number
Incidence
(95% BCI) Number
Incidence
(95% BCI)
Eastern and western 
Europeg 401
2.6
(2.1–3.2) 461
3.0
(2.4–3.7) 191
1.3
(1.0–1.6) 140
0.9
(0.7–1.2)
Germany 26 0.8(0.5–1.1) 20
0.6
(0.3–0.9) 7
0.2
(0.1–0.4) 6
0.2
(0.1–0.3)
United Kingdom 13 0.4(0.2–0.7) 7
0.2
(0.1–0.4) 0
0.0
(0–0) 5
0.1
(0–0.3)
France 50 2.6(1.7–3.6) 16
0.8
(0.4–1.3) 9
0.5
(0.2–0.8) 2
0.1
(0–0.3)
The Netherlands 10 1.2(0.5–2.3) 1
0.1
(0–0.5) 1
0.1
(0–0.5) 0
0.0
(0–0)
Poland 4 0.5(0.1–1.3) 4
0.5
(0.1–1.2) 0
0.0
(0–0) 2
0.2
(0–0.8)
Austria 103 11.7(8.3–15.7) 8
0.9
(0.4–1.7) 5
0.6
(0.2–1.2) 2
0.2
(0–0.7)
Switzerland 39 9.6(6.3–13.9) 8
2.0
(0.8–3.7) 1
0.3
(0–1.0) 3
0.8
(0.2–1.8)
Hungary 6 0.6(0.2–1.3) 6
0.6
(0.2–1.3) 2
0.2
(0–0.6) 2
0.2
(0–0.6)
Belgium 7 4.2(1.5–8.6) 3
1.8
(0.4–4.7) 1
0.6
(0–2.4) 1
0.6
(0–2.4)
Southern Europe and
the eastern 
Mediterraneanh
4,034 14.0(11.4–16.7) 14,607
50.6
(40.7–60.4) 4,655
16.2
(13.4–19.2) 6,199
21.4
(17.4–25.4)
Spain including 
Canary Islands 1,863
12.7
(9.2–17.0) 8,128
55.0
(39.7–74.7) 2,201
15.1
(10.9–20.1) 4,140
27.6
(20.1–35.5)
Spain excluding 
Canary Islands 631
10.3
(7.6–13.5) 1,945
31.7
(23.2–42.0) 439
7.2
(5.3–9.6) 976
16.1
(11.8–21.3)
Canary Islands 1,232 14.6(8.9–22.9) 6,183
72.3
(47.8–107.6) 1,762
21.4
(13.2–32.8) 3,164
36.7
(23.1–56.6)
Greece 1,137 22.5(16.2–29.8) 2,682
52.8
(37.7–70.6) 598
11.9
(8.6–15.7) 1,107
21.9
(15.9–29.0)
Italy 53 2.1(1.5–2.9) 53
2.1
(1.5–2.9) 7
0.3
(0.1–0.5) 26
1.0
(0.6–1.6)
Turkey 775 29.7(22.7–37.7) 3,353
127.4
(97.9–161.4) 1,766
67.9
(52.5–85.3) 786
30.2
(22.9–38.3)
Portugal 26 1.4(0.8–2.4) 16
0.9
(0.4–1.6) 6
0.3
(0.1–0.7) 7
0.4
(0.1–0.8)
Asia and Oceania 1,089 8.2(5.4–11.8) 5,042
37.4
(23.8–53.5) 2,663
20.6
(14.2–29.5) 1,170
8.9
(5.9–13.0)
Thailand 946 23.7(14.6–36.4) 4,538
112.0
(66.0–165.3) 2,341
59.0
(37.5–90.8) 1,088
27.8
(17.5–41.4)
China 27 1.4(0.9–2.2) 37
2.0
(1.2–2.9) 14
0.8
(0.4–1.3) 13
0.7
(0.3–1.2)
The Americas 89 1.3(0.8–2.0) 244
3.5
(2.1–5.3) 120
1.8
(1.1–2.7) 67
1.0
(0.6–1.5)
United States 34 0.9(0.4–1.6) 45
1.2
(0.6–2.1) 7
0.2
(0.1–0.4) 17
0.4
(0.2–0.9)
Africa 181 6.7(3.8–10.5) 1,977
77.0
(48.3–119.5) 1,684
63.0
(38.0–100.3) 179
6.6
(3.9–10.5)
Egypt 144 15.6(9.0–25.2) 1,904
197.9
(114.7–308.1) 1,631
184.6
(110.6–290.5) 173
18.6
(10.7–29.8)
BCI = Bayesian credible interval. 
a  Data from the Official Statistics of Finland (OSF): overnight leisure and business trips abroad; includes travellers aged 15–74 years in 
2010–11 and travellers aged 15–84 years in 2012 [22].
b  The geographical classification used by OSF was used for the calculation of incidence. 
c  Country-specific data from OSF were only available for countries receiving more than 50,000 Finnish visitors per year.
d  Includes cases aged 15–74 years in 2010–11 and 15–84 years in 2012, who sought medical care abroad during 2010 to 2012, handled by SOS 
International. A case was defined as a Finnish traveller abroad with one episode of illness or injury, handled by SOS International during 
2010 to 2012. A person with several separate episodes was counted more than once.
e  The data of SOS International cover about 95% of Finnish cases handled by assistance organisations of insurance companies.
f  Incidence per 100,000 travel days = (number of cases divided by number of travel days) x 100,000.
g  Figures for Nordic and Baltic countries and Russia are not presented here; incidences for these countries  are not comparable with those of 
other regions because proportionally more cases are covered by the Social Insurance Institution of Finland (Kela) [24] and trips are shorter 
than to other regions [22].
h  Balkan states, Cyprus, Greece, Israel, Italy, Malta, Portugal including Madeira, Spain including Canary Islands, Turkey.
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proved highest in Egypt, Turkey, and Thailand, and var-
ied between countries within southern Europe.
Infection incidence was greatest in Africa, followed 
by southern Europe plus the eastern Mediterranean, 
and Asia plus Oceania. As for injuries, incidence 
proved highest in southern Europe plus the eastern 
Mediterranean (Table 4, Figure 3).
Discussion
Principal findings
For decades, travel medicine research has striven to 
outline the risks of health problems at various destina-
tions. As data have been unrelated to numbers of trav-
ellers per site, the main point of criticism has been that 
proportions of health problems easily suffer distortion 
[20]. Some reports have described single imported 
diseases in relation to national travel statistics [25] or 
World Tourism Organization data [26,27], but a thor-
ough overview of travellers’ health risks has been 
lacking.
Our investigation draws on the exceptional situation in 
Finland, with two large databases available: one main-
tained by a single travellers’ assistance organisation, 
covering about 95% of Finnish cases, and the other 
by OSF, providing numerical data on Finnish travellers 
to various destinations. Combining these enabled not 
only a virtually comprehensive nationwide analysis 
of proportionate morbidity for various diagnoses, but 
also incidence calculation of health problems abroad. 
These data reveal the great incidence of infections and 
the significant difference in incidence of illness and 
injury between the various regions.
Figure 3
Infections and injuries of Finnish travellersa by geographical regionsb, 2010–2012 (9,953,000 travellers) 
A: eastern and western Europe; B: southern Europe and the eastern Mediterranean; C: Africa; D: Asia and Oceania; E: the Americas. 
‘Other’ refers to diagnoses other than infections or injuries (skin diseases; musculoskeletal and connective tissue diseases; diseases of 
the digestive tract;  vascular diseases; neoplasms; haematological diseases; endocrine, nutritional and metabolic diseases; mental 
and behavioural disorders; neurological diseases; eye diseases; ear diseases; respiratory diseases; genitourinary diseases; pregnancy, 
childbirth and perinatology; unclassified symptoms). 
a  Includes cases aged 15–74 years in 2010–11, and those aged 15–84 years in 2012. A case was defined as a Finnish traveller abroad with one 
episode of illness or injury, handled by SOS International during 2010 to 2012. A person with several separate episodes was counted more 
than once.
b  Figures for Nordic and Baltic countries and Russia are not presented here; incidences for these countries  are not comparable with those of 
other regions because proportionally more cases are covered by the Social Insurance Institution of Finland (Kela) [24] and trips are shorter 
than to other regions [22].
Data source: Table 4.
Infections
Injuries
Other
Infections
Injuries
A 3 3
B 51 14
C 77 7
D 37 8
E 4 1
15
6113
26
78
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55
30
40
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X  
X
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(pie charts)
Incidence per 100,000 travel days
(boxes)
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Strengths and weaknesses
The major novelty of our work lies in presenting inci-
dences of illnesses and injuries in various geographi-
cal regions. Even though the proportionate morbidity 
data presented in this and previous [2-19] studies are 
very informative, the incidence figures are of special 
value, as they describe more accurately the risks for 
travellers and, as illustrated in Figure 3, allow compari-
sons between various regions. Our study sample rep-
resents the most severe cases, yet the actual incidence 
of health problems among travellers needing medical 
care abroad may in reality be sixfold higher than that 
presented here (Figure 1). While this study is, to the 
best of our knowledge, the largest to date reporting 
health problems of travellers while abroad, the data do 
not cover travellers who did not contact insurance com-
panies/assistance organisations, nor those without 
insurance, or those making a claim afterwards directly 
to the insurance company. According to Finland’s larg-
est travel insurance company, the last group men-
tioned comprise mostly uncomplicated outpatient 
cases, while nearly all inpatients abroad are cared for 
by assistance organisations (Ilkka Valanne, Claims 
Specialist, Eurooppalainen, personal communication, 2 
October 2013). As our study material covers 95% of all 
Finnish cases handled by assistance organisations, the 
data represent quite comprehensively the most serious 
health problems faced by Finnish travellers.
The SOS database lacked information on duration of 
and reason for travel, and itinerary of individual cases, 
and no evaluations could be made in relation to these 
factors. Studies relying on questionnaires and tel-
ephone interviews [2,7-14] represent travellers’ own 
reports, not evaluations made by healthcare profes-
sionals; those based on travel insurance claims [15,16] 
are a mixture of both. One of the strengths of our study 
is data collection directly from clinicians treating the 
patient abroad.
Results in relation to findings in other studies
Findings on proportionate morbidity
In our study, infections clearly outnumbered all other 
health problems during travel. The proportion of infec-
tions proved higher than in studies from Switzerland, 
Australia and Norway, also using data of assistance 
organisations (60% vs 20–40%) [17-19], possibly 
because, instead of organ-specific categories, we 
grouped all infections together, in a category of their 
own.
The most common single diagnosis was acute gastro-
enteritis (23%), consistent with previous findings on 
illness abroad [2,8-14,28], accounting for one third of 
inpatient cases. Respiratory infections proved nearly 
as common (21%), yet with less frequent hospitalisa-
tion than for gastroenteritis. In prospective studies, 
respiratory infections have been reported in 2–26% of 
travellers [2,7-14]. 
Findings on incidence of illness and injury
The overall incidence proved highest in Africa, south-
ern Europe plus the eastern Mediterranean, and Asia 
plus Oceania. One remarkable finding was that in 
southern Europe plus the eastern Mediterranean, fig-
ures for injuries and infections proved higher than 
those for eastern plus western Europe. The infection 
profile differed from that in Africa and Asia: instead 
of acute gastroenteritis, incidence in southern Europe 
plus the eastern Mediterranean was highest for respir-
atory tract infections, except for Turkey, which showed 
the opposite.
Comparisons of incidence figures were possible 
between countries with more than 50,000 annual visi-
tors. Some caution should, however, be used when mak-
ing comparisons, since differences between healthcare 
services may influence the figures in Europe: in coun-
tries with large numbers of tourists, such as Spain, 
there are private clinics directly contacting assistance 
organisations, whereas for countries with fewer private 
hospitals, the proportion of cases reported to SOS may 
remain smaller.
In eastern plus western Europe, where data could be 
compared between several countries, there was on the 
whole a minor incidence of health problems. The inci-
dence of injuries was high in Austria and Switzerland, 
probably mostly accounted for by skiing accidents 
(Mikael Fotopoulos, SOS International, personal com-
munication, 14 July 2014). In southern Europe plus the 
eastern Mediterranean, comparisons could be made 
between Greece, Italy, Portugal, Spain, and Turkey. 
In Italy and Portugal, overall incidence of illness and 
injury proved similar to that in eastern plus west-
ern Europe. The high overall incidence in Turkey was 
attributed to gastroenteritis, whereas the next highest 
figures in Greece and Spain were mainly due to respira-
tory tract infections. Greenwood et al. described a low 
risk of gastroenteritis for southern Europe [27], yet we 
found an elevated incidence in Greece and Spain.
The incidence figures reflect not only health haz-
ards, but also the characteristics of travellers: in the 
multivariable analysis, vascular diseases, male sex 
and age ≥ 60 years, for example, were risk factors for 
hospitalisation.
Likelihood of illness increases with duration of travel 
[2,29]. In the OSF data, the farther the destination, the 
longer was the stay (Table 3). For travellers to southern 
Europe plus the eastern Mediterranean, the median 
duration was longest for the Canary Islands; interme-
diate for mainland Spain, Greece and Portugal; and 
shortest for Turkey and Italy. The overall incidence of ill-
ness and injury proved, however, highest in Turkey and 
the Canary Islands, followed by Greece and mainland 
Spain. Thus, length of stay alone does not account for 
these differences. Within this same region, travellers 
to the Canary Islands were older, and to Italy younger 
than those to other destinations, consistent with the 
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age distribution of our cases. Travellers’ age and travel 
duration may thus partly explain the high incidence in 
the Canary Islands and the low in Italy. Nevertheless, it 
appears that the overall incidence in southern Europe 
plus the eastern Mediterranean exceeded that else-
where in Europe.
Conclusions
This study shows a clear predominance of infections 
among Finnish travellers’ health problems. This inves-
tigation is the first to present such comprehensive data 
on incidence of illnesses and injuries during travel. It 
thus provides tools for risk assessment, destination-
specific travel counselling and post-travel evaluation. 
As the types of exposure in a given destination are 
alike for all travellers, regardless of the country of ori-
gin, the results of this study should be applicable to 
any country with a similar travel pattern.
A noteworthy conclusion is that travel within Europe is 
not without risk. Pre-travel advice may also be needed 
also for visitors to southern Europe.
*Erratum
In Table 3, the number of travellers in eastern and western 
Europe were incorrect. Also the median age group for Spain 
excluding the Canary Islands was incorrect. These errors 
were corrected on 25 May 2015, at the request of the authors.
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